The efficacy of generic imatinib in patients with chronic myeloid leukemia: A single centre experience

Background/Aim. The treatment of chronic myeloid leukemia (CML) has changed dramatically with the advent of targeted therapies. This study aimed to assess the efficacy of generic imatinib in CML patients treated in our center. Methods. The study was retrospective. It included 101 patients diagnosed...

Full description

Bibliographic Details

Published in:	Vojnosanitetski Pregled
Main Authors:	Urošević Ivana, Perčić Ivanka, Dragičević-Jojkić Marina, Dokić Marina, El Farra Amir, Savić Aleksandar, Milošević Ivana, Vlaisavljević Nada, Sekulić Borivoj, Balint Bela
Format:	Article
Language:	English
Published:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
Subjects:	leukemia, myeloid, chronic-phase imatinib mesylate drugs, generic survival
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900095U.pdf